Richter Transformation clinical trials at UCSF

1 research study open to eligible people

Richter transformation is when a type of blood cancer changes into a more aggressive form. UCSF is studying NX-1607 to see how safe it is and how well it works against cancer. This trial is for adults with advanced stages of cancer.

Showing trials for

  • NX-1607 in Adults With Advanced Malignancies

    open to eligible people ages 18 years and up

    This is a first-in-human Phase 1a/1b multicenter, open-label oncology study designed to evaluate the safety and anti-cancer activity of NX-1607 in patients with advanced malignancies.

    San Francisco, California and other locations

Our lead scientists for Richter Transformation research studies include .

Last updated: